Single-Center Experience of Treating Chronic Limb-Threatening Ischemia of Lower Limbs Combined with Diabetes

LUO Xin, HUANG Ke, HUANG Bin, WEN Xin, LI Yi-yuan, ZHAO Ji-chun, RAN Xing-wu, CHEN Da-wei, GAO Yun, CHEN Xi-yang, DU

Abstract

To summarize our hospital’s single-center experience of and reflections on the treatment of chronic limb-threatening ischemia (CLTI) of lower limbs combined with diabetes in the past 5 years.   Methods  We retrospectively analyzed cases of lower limb CLTI combined with diabetes diagnosed at our hospital from March 2017 to June 2021. The baseline data, surgical information, and follow-up results of the patients were collected. The primary outcome indicator was the patency rate of lower limb target artery within 1 year post-op, and the secondary indicators were the reoperation rate within 1 year post-op and the amputation rate within 1 year post-op.   Results  A total of 89 patients with lower limb CLTI combined with diabetes were included in the study. A total of 85 patients underwent percutaneous transluminal angioplasty and the operation of 7 patients ended in failure, with the operation success rate reaching 91.76% (78/85). Three patients underwent femoral popliteal artery bypass grafting with artificial blood vessels and one patient underwent iliac femoral artery bypass grafting with artificial blood vessels, with the success rate of the operations reachign 100% (4/4). Among 78 patients who successfully underwent percutaneous transluminal angioplasty, the median follow-up time was 33 months (13, 64). Two patients died within one year after operation, with the post-op one-year survival rate being 97.44% (76/78). The post-op 1-year reoperation rate was 19.23% (15/78), the 1-year target vascular patency rate (deaths not included) was 85.53% (65/76), and the 1-year amputation rate was 3.85% (3/78). Among the patients who underwent bypass surgery, the follow-up period was 13-48 months. No thrombosis in or re-occlusion of the artificial blood vessels were observed during the follow-up period, and the artificial blood vessels remained unoccluded.   Conclusion  Transluminal angioplasty has a relatively ideal rate of postoperative vascular patency. In addition, it is a minimally invasive procedure involving low perioperative risks and is performed under local anesthesia. Therefore, it can be used as the preferred treatment for patients with CLTI. On the other hand, bypass surgery has good long-term patency rate, but it involves higher perioperative risks and the procedure is more invasive. Therefore, bypass surgery can be used as an alternative when transluminal angioplasty ends in failure.

 

Keywords: Chronic limb-threatening ischemia, Diabetes mellitus, Percutaneous transluminal angioplasty, Bypass surgery

 

Full Text:

PDF


References


POLONSKY T S， MCDERMOTT M M. Lower extremity peripheral artery disease without chronic limb-threatening ischemia: A review. JAMA，2021，325(21): 2188–2198.

ARMSTRONG E J. Advances in the treatment of chronic limb-threatening ischemia. J Endovasc Ther，2020，27(4): 521–523.

SHAN L L， SHI M D Y， TEW M， et al. Measuring quality of life in chronic limb-threatening ischemia patients and informal carers: A scoping review. Ann Surg，2022，276(5): e331–e341.

FARBER A. Chronic limb-threatening ischemia. N Engl J Med，2018， 379(2): 171–180.

CONTE M S， BRADBURY A W， KOLH P， et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg，2019，58(1s): S1–S109.e33.

MISHRA S C， CHHATBAR K C， KASHIKAR A， et al. Diabetic foot. BMJ， 2017， 359: j5064[2022-06-05]. https://doi.org/10.1136/bmj.j5064. BHANDARI N， NEWMAN J D， BERGER J S， et al. Diabetes mellitus and outcomes of lower extremity revascularization for peripheral artery disease. Eur Heart J Qual Care Clin Outcomes，2022，8(3): 298–306.

ALMASRI J， ADUSUMALLI J， ASI N， et al. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia. J Vasc Surg，2018，68(2): 624–633.

CONTE M S， MILLS J L， BRADBURY A W， et al. Implementing global chronic limb-threatening ischemia guidelines in clinical practice: Utility of the society for vascular surgery threatened limb classification system (wifi). J Vasc Surg，2020，72(4): 1451–1452.

MILLS J L. Modern treatment of chronic limb-threatening ischemia requires a PLAN, clinical judgment, and shared decision making. J Vasc Surg，2020，72(2): 389–390.

MILLS J L， CONTE M S， ARMSTRONG D G， et al. The Society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (wifi). J Vasc Surg，2014，59(1): 220–34.e1-2.

CONTE M S， BRADBURY A W， KOLH P， et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg，2019，69(6s): 3S–125S.e40.

ELBADAWI A， ELGENDY I Y， SAAD M， et al. Contemporary revascularization strategies and outcomes among patients with diabetes with critical limb ischemia: Insights from the national inpatient sample. JACC Cardiovasc Interv，2021，14(6): 664–674.

LIANG P， SODEN P A， ZETTERVALL S L， et al. Treatment outcomes in diabetic patients with chronic limb-threatening ischemia. J Vasc Surg， 2018，68(2): 487–494.

BUTALA N M， RAJA A， XU J， et al. Association of frailty with treatment selection and long-term outcomes among patients with chronic limb-threatening ischemia. J Am Heart Assoc， 2021， 10(24): e023138[2022-06-05]. https://doi.org/10.1161/jaha.121.023138.

JORET M O， OSMAN K， DEAN A， et al. Multidisciplinary clinics reduce treatment costs and improve patient outcomes in diabetic foot disease. J Vasc Surg，2019，70(3): 806–814.

SHAN L L， WANG J， WESTCOTT M J， et al. A Systematic review of cost-utility analyses in chronic limb-threatening ischemia. Ann Vasc Surg，2022，85: 9–21.

HINGORANI A， LAMURAGLIA G M， HENKE P， et al. The management of diabetic foot: A clinical practice guideline by the society for vascular surgery in collaboration with the american podiatric medical association and the society for vascular medicine. J Vasc Surg，2016，63 (2 Suppl): 3S–21S.

CHEN S L， WHEALON M D， KABUTEY N K， et al. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease. J Vasc Surg，2017，65(6): 1680–1689.

LEVIN S R， ARINZE N， SIRACUSE J J. Lower extremity critical limb ischemia: A review of clinical features and management. Trends Cardiovasc Med，2020，30(3): 125–130.

BENEDETTO F， SPINELLI D， PIPITÒ N， et al. Inframalleolar bypass for chronic limb-threatening ischemia. Vasc Med，2021，26(2): 187–194.

JONES D W， FARBER A. Review of the global vascular guidelines on the management of chronic limb-threatening ischemia. JAMA Surg，2020， 155(2): 161–162.


Refbacks

  • There are currently no refbacks.